We use cookies for analytics and ads to improve your experience. You can accept or decline. See our Privacy Policy.
Unlisted shares are illiquid and carry higher risk than listed securities. Prices are indicative, not live. Read the risk disclosure.

Valuation
Financials (FY2024)
Investment Thesis
Adret Retail (Kapiva) is a high-growth consumer brand play in India's booming Ayurvedic wellness segment, backed by credible institutional investors and a strong founding team with heritage in the Dabur ecosystem. While profitability remains a near-term challenge, the brand's differentiated positioning, omnichannel scale, and large addressable market make it an attractive pre-IPO opportunity for investors with a 3–5 year horizon.
Pros
Cons
Business Segments
Herbal Nutrition & Supplements
Ayurvedic health supplements including ashwagandha, shilajit, chyawanprash, and other immunity and wellness products
Herbal Juices & Beverages
Range of Ayurvedic juices such as aloe vera, amla, karela jamun, and noni targeted at daily health routines
Personal Care & Herbal Ghee
Skincare, haircare products and A2 herbal ghee variants based on Ayurvedic ingredient science
Revenue Model
Kapiva primarily earns revenue through direct-to-consumer (D2C) sales via its own website, supplemented by e-commerce marketplaces (Amazon, Flipkart, Blinkit, Zepto) and a growing offline retail presence. The company uses a subscription and repeat-purchase model for wellness products, enhancing customer lifetime value. Revenue is product-based with no licensing or SaaS component.
Detailed Analysis
Growth Plans
Potential IPO in 2025–2027 window as D2C FMCG listings gain traction
India's herbal & Ayurvedic FMCG market projected to reach ₹1,00,000 Cr by 2030
Expansion into international markets (Middle East, Southeast Asia) for diaspora consumers
New category entries in protein nutrition and women's wellness
Industry Tailwinds
Recent Developments
Kapiva expanded its presence on quick-commerce platforms including Blinkit and Zepto to tap into impulse-driven wellness purchases in Tier 1 cities.
2024-01Kapiva launched plant-based protein powders to compete in the fast-growing sports nutrition and fitness supplement category.
2023-09The company significantly scaled its offline retail presence through modern trade and general trade channels, reducing dependence on online-only sales.
2023-06Comparable Companies
Frequently Asked Questions
About Adret Retail
Adret Retail Private Limited is an Indian retail company. The company operates in India's growing retail sector, which has been undergoing significant transformation through organised retail expansion, e-commerce growth, and changing consumer preferences.
Key Milestones
Founded in 2016 in Bengaluru by Ameve Sharma and Shrey Badhani as Adret Retail Private Limited
Launched Kapiva brand positioning modern Ayurveda for millennial consumers
Raised seed and Series A funding from Fireside Ventures between 2018–2020
Common questions about unlisted shares
You buy from and sell to the wisefolio desk — shares route through the desk's demat, money-in before shares-out.
You enquire
· Takes 2 minutesTell us the company and quantity you want. Share your demat details so we can settle directly into your account.
We source & quote
· Typically within 1 business dayOur desk sources the shares and comes back with a firm price and an allocation for the quantity available.
You accept the allocation
· Quote valid for 3 daysReview the price, quantity and total. Accept to lock the allocation. The quote is valid for a short window before it needs re-pricing.
You transfer the funds
· Pay within 2 days of acceptingPay by direct bank transfer to the desk's published account — never to a personal account. We confirm receipt and begin the transfer.
Shares reach your demat
· Usually credited within 2–3 business daysOnce payment is verified, the shares are transferred from the desk's demat into yours, and you receive a transfer confirmation.
A principal desk for unlisted & pre-IPO shares — you transact with us, not a stranger.
You enquire
Takes 2 minutes
We source & quote
Typically within 1 business day
You accept the allocation
Quote valid for 3 days
You transfer the funds
Pay within 2 days of accepting
Shares reach your demat
Usually credited within 2–3 business days
Unlisted shares are illiquid and carry higher risk. Pricing is indicative, not live, and these are private off-market transactions with no exchange settlement guarantee. Read the full risk disclosure.
Be the first to discuss Adret Retail — share your research, ask questions, or compare notes with other investors.
Potential IPO in 2025–2027 window as D2C FMCG listings gain traction
India's herbal & Ayurvedic FMCG market projected to reach ₹1,00,000 Cr by 2030
Expansion into international markets (Middle East, Southeast Asia) for diaspora consumers
New category entries in protein nutrition and women's wellness
Industry Headwinds
Sustained losses if customer acquisition costs don't normalize
Potential margin pressure from offline channel expansion
Tightening of AYUSH regulatory environment
Faces intense competition from established FMCG giants like Dabur, Himalaya, Patanjali, Emami, and well-funded startups like Mamaearth and The Moms Co.
Source: Media Reports / Public Records
AYUSH product regulations and advertising standards for health claims can restrict marketing flexibility and require ongoing compliance investment.
Source: Regulatory Filings
High customer acquisition costs in D2C and quick-commerce channels, combined with competitive pricing pressure, may delay the path to profitability.
Source: Media Reports / Public Records
As an unlisted private company, investors face significant illiquidity risk with no guaranteed exit path short of an IPO or acquisition.
Source: Media Reports / Public Records
Dependence on Ayurvedic raw material sourcing (herbs, botanicals) exposes the company to agricultural commodity price volatility and quality consistency risks.
Source: AlphaHub Research
Faces intense competition from established FMCG giants like Dabur, Himalaya, Patanjali, Emami, and well-funded startups like Mamaearth and The Moms Co.
AYUSH product regulations and advertising standards for health claims can restrict marketing flexibility and require ongoing compliance investment.
High customer acquisition costs in D2C and quick-commerce channels, combined with competitive pricing pressure, may delay the path to profitability.
As an unlisted private company, investors face significant illiquidity risk with no guaranteed exit path short of an IPO or acquisition.
Dependence on Ayurvedic raw material sourcing (herbs, botanicals) exposes the company to agricultural commodity price volatility and quality consistency risks.
DABUR · ~₹85,000 Cr
PE: ~45xx
Unlisted · ~₹30,000 Cr (estimated)
EMAMILTD · ~₹20,000 Cr
PE: ~38xx
HONASA · ~₹8,000 Cr
PE: ~60xx
Secured investment from the Burman family (Dabur promoters), adding strategic credibility in FMCG
Expanded to 10,000+ retail touchpoints across offline and online channels by 2023
Crossed ₹200 Cr annualized revenue run-rate by FY2024